{"id":"https://openalex.org/W7225377174","doi":"https://doi.org/10.6084/m9.figshare.34937333","title":"Nanobodies as next-generation antigen recognition domains for CAR-based cellular immunotherapies in cancer","display_name":"Nanobodies as next-generation antigen recognition domains for CAR-based cellular immunotherapies in cancer","publication_year":2026,"publication_date":"2026-11-06","ids":{"openalex":"https://openalex.org/W7225377174","doi":"https://doi.org/10.6084/m9.figshare.34937333"},"language":"en","primary_location":{"id":"doi:10.6084/m9.figshare.34937333","doi":"https://doi.org/10.6084/m9.figshare.34937333","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.34937333","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.6084/m9.figshare.34937333","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5161128062","display_name":"Amirhosein Maali","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amirhosein Maali","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161029057","display_name":"Shaghayegh Fazelian","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shaghayegh Fazelian","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161122696","display_name":"Mahdieh Jafari","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mahdieh Jafari","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5055283322","display_name":"Zahra Sharifzadeh","orcid":"https://orcid.org/0000-0002-4419-0315","observed_orcids":["https://orcid.org/0000-0002-4419-0315"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zahra Sharifzadeh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nanobodies","display_name":"nanobodies","score":0.9559999704360962},{"id":"https://openalex.org/keywords/chimeric-antigen-receptor","display_name":"chimeric antigen receptor","score":0.9620000123977661},{"id":"https://openalex.org/keywords/chimeric-antigen-receptor-t-cells","display_name":"chimeric antigen receptor T cells","score":0.8050000071525574},{"id":"https://openalex.org/keywords/car-nk-cells","display_name":"CAR-NK cells","score":0.984000027179718},{"id":"https://openalex.org/keywords/car-macrophages","display_name":"CAR macrophages","score":0.9559999704360962},{"id":"https://openalex.org/keywords/antigen-recognition","display_name":"antigen recognition","score":0.4480000138282776},{"id":"https://openalex.org/keywords/tumor-heterogeneity","display_name":"tumor heterogeneity","score":0.7689999938011169},{"id":"https://openalex.org/keywords/tumor-escape","display_name":"tumor escape","score":0.4399999976158142},{"id":"https://openalex.org/keywords/synthetic-antigens","display_name":"synthetic antigens","score":0.38100001215934753},{"id":"https://openalex.org/keywords/graft-versus-host-disease","display_name":"graft-versus-host disease","score":0.8389999866485596},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.6380000114440918},{"id":"https://openalex.org/keywords/cellular-immunotherapy","display_name":"cellular immunotherapy","score":0.6570000052452087},{"id":"https://openalex.org/keywords/cancer","display_name":"cancer","score":0.5690000057220459}],"concepts":[{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.8766999840736389},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.6140999794006348},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5819000005722046},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5733000040054321},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.5401999950408936},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.5320000052452087},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5235000252723694},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.4569999873638153},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4503999948501587},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3912000060081482},{"id":"https://openalex.org/C136449434","wikidata":"https://www.wikidata.org/wiki/Q428253","display_name":"Innate immune system","level":3,"score":0.3898000121116638},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3840000033378601},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.36800000071525574},{"id":"https://openalex.org/C108249834","wikidata":"https://www.wikidata.org/wiki/Q3922363","display_name":"Antigen processing","level":5,"score":0.3118000030517578},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.3057999908924103},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.302700012922287},{"id":"https://openalex.org/C83464605","wikidata":"https://www.wikidata.org/wiki/Q575296","display_name":"Antigen presentation","level":4,"score":0.28519999980926514},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.28519999980926514},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.28380000591278076},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.28040000796318054},{"id":"https://openalex.org/C2778326572","wikidata":"https://www.wikidata.org/wiki/Q7852668","display_name":"Tumor-infiltrating lymphocytes","level":4,"score":0.2802000045776367},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.26660001277923584},{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.2648000121116638},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.2621999979019165},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.2621999979019165},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.2515000104904175}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.6084/m9.figshare.34937333","doi":"https://doi.org/10.6084/m9.figshare.34937333","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.34937333","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},{"id":"doi:10.6084/m9.figshare.34937333.v1","doi":"https://doi.org/10.6084/m9.figshare.34937333.v1","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.34937333.v1","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.6084/m9.figshare.34937333","doi":"https://doi.org/10.6084/m9.figshare.34937333","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.34937333","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4414027133","https://openalex.org/W4400263562","https://openalex.org/W4416809173","https://openalex.org/W4224310088","https://openalex.org/W3128431431","https://openalex.org/W4318043882","https://openalex.org/W4393197729","https://openalex.org/W4415517990","https://openalex.org/W2785484365","https://openalex.org/W4411054666"],"abstract_inverted_index":{"Nanobody-based":[0,77],"chimeric":[1,229],"antigen":[2,35,169,230],"receptors":[3],"(CARs)":[4],"represent":[5,406],"a":[6,202],"promising":[7,380],"strategy":[8],"for":[9,109,155,410,426],"improving":[10],"the":[11,151,208,221,281],"specificity,":[12],"modularity,":[13],"and":[14,37,56,64,66,74,84,87,95,106,122,132,144,157,171,178,189,196,215,244,266,297,307,338,355,367,388,400,422],"clinical":[15,180,197,376],"adaptability":[16],"of":[17,72,82,153,220,225,258,284],"cellular":[18],"immunotherapies.":[19],"Replacing":[20],"conventional":[21,289],"single-chain":[22],"variable":[23,27],"fragments":[24],"with":[25,103,119,288,428],"camelid-derived":[26],"heavy-chain":[28],"domains":[29],"(VHHs)":[30],"may":[31,123,417],"enhance":[32],"receptor":[33,231],"stability,":[34],"accessibility,":[36],"construct":[38],"design.":[39],"This":[40],"review":[41],"summarizes":[42],"nanobody-based":[43,319,344,403],"CAR":[44,147,249,285,320,345,365,368,404],"applications":[45],"across":[46],"T":[47,54,114,330,336],"cells,":[48,52,55,261,328,331,334,337],"natural":[49,332],"killer":[50,333],"(NK)":[51],"\u03b3\u03b4":[53],"macrophages,":[57],"drawing":[58],"on":[59],"literature":[60],"published":[61],"between":[62],"2011":[63],"2026":[65],"identified":[67],"through":[68],"PubMed/MEDLINE,":[69],"Scopus,":[70],"Web":[71],"Science,":[73],"Google":[75],"Scholar.":[76],"CAR-T":[78],"cells":[79,99,115,237,369],"support":[80,356],"recognition":[81,257],"hematologic":[83],"solid":[85],"tumors":[86],"facilitate":[88],"dual":[89],"targeting,":[90],"tandem":[91],"receptors,":[92],"affinity":[93],"tuning,":[94],"immune-modulating":[96],"designs.":[97],"CAR-NK":[98],"combine":[100],"antigen-directed":[101],"activity":[102,381],"innate":[104],"cytotoxicity":[105],"potential":[107],"advantages":[108],"allogeneic,":[110],"off-the-shelf":[111],"treatment.":[112],"CAR-\u03b3\u03b4":[113],"integrate":[116],"innate-like":[117],"surveillance":[118],"engineered":[120],"specificity":[121],"offer":[124,163],"reduced":[125],"graft-versus-host":[126],"disease":[127],"risk.":[128],"CAR-macrophages":[129],"exploit":[130],"phagocytosis":[131],"tumor":[133,167,353],"microenvironment":[134],"remodeling":[135],"to":[136,165,184,213,241,299,303],"promote":[137],"antitumor":[138],"responses.":[139],"Emerging":[140],"universal,":[141],"switchable,":[142],"-generated,":[143],"synthetic":[145],"antigen-based":[146],"platforms":[148],"further":[149,175],"highlight":[150],"versatility":[152],"nanobodies":[154,292],"controllable":[156],"scalable":[158],"therapies.":[159,286,312],"Collectively,":[160],"these":[161],"approaches":[162],"opportunities":[164],"address":[166],"heterogeneity,":[168],"escape,":[170],"treatment":[172,227,262,358],"safety,":[173],"although":[174],"preclinical":[176],"optimization":[177],"rigorous":[179],"evaluation":[181],"are":[182,238,271,293,322],"needed":[183],"establish":[185],"their":[186],"efficacy,":[187],"persistence,":[188],"long-term":[190,398],"safety":[191,396],"in":[192,234,268,382],"diverse":[193],"patient":[194],"populations":[195],"settings.":[198],"Cancer":[199],"immunotherapy":[200],"is":[201,228],"rapidly":[203],"developing":[204],"approach":[205],"that":[206,276,343,370],"uses":[207],"patient\u2019s":[209],"own":[210],"immune":[211,236,310,327],"system":[212],"recognize":[214],"destroy":[216],"cancer":[217,260,349,413],"cells.":[218],"One":[219],"most":[222],"advanced":[223],"forms":[224],"this":[226,314],"(CAR)":[232],"therapy,":[233],"which":[235],"genetically":[239],"modified":[240],"better":[242],"identify":[243],"attack":[245],"tumors.":[246],"However,":[247],"current":[248],"therapies":[250,346,405,425],"still":[251],"face":[252],"several":[253],"challenges,":[254],"including":[255,329,395],"limited":[256],"some":[259],"resistance,":[263],"side":[264],"effects,":[265],"difficulties":[267],"manufacturing.":[269],"Nanobodies":[270],"very":[272],"small":[273],"antibody-like":[274],"molecules":[275],"can":[277,347],"be":[278],"used":[279],"as":[280,361,386],"cancer-recognizing":[282],"part":[283],"Compared":[287],"antibody":[290],"fragments,":[291],"more":[294,305,420],"compact,":[295],"stable,":[296],"easier":[298],"modify,":[300],"allowing":[301],"scientists":[302],"design":[304],"flexible":[306],"potentially":[308],"safer":[309],"cell":[311,350],"In":[313],"review,":[315],"we":[316],"discuss":[317],"how":[318],"systems":[321],"being":[323],"developed":[324],"using":[325],"different":[326],"gamma-delta":[335],"macrophages.":[339],"Recent":[340],"studies":[341,377],"show":[342],"improve":[348],"recognition,":[351],"overcome":[352],"diversity,":[354],"new":[357],"designs":[359],"such":[360,385],"multi-target":[362],"CARs,":[363],"universal":[364],"platforms,":[366],"release":[371],"additional":[372],"immune-activating":[373],"molecules.":[374],"Early":[375],"have":[378],"demonstrated":[379],"blood":[383],"cancers":[384],"leukemia":[387],"multiple":[389],"myeloma.":[390],"Although":[391],"important":[392],"challenges":[393],"remain,":[394],"control,":[397],"effectiveness,":[399],"large-scale":[401],"production,":[402],"an":[407],"exciting":[408],"direction":[409],"future":[411],"personalized":[412],"treatments.":[414],"Continued":[415],"research":[416],"help":[418],"develop":[419],"adaptable":[421],"accessible":[423],"immune-based":[424],"patients":[427],"difficult-to-treat":[429],"cancers.":[430]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-11-07T00:00:00"}